Comparative outcome assessment of epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of advanced non-small-cell lung cancer: a network meta-analysis

INTRODUCTION: Tyrosine kinase inhibition of the epidermal growth factor receptor (EGFR) is the standard in the first line treatment of patients with advanced non-small–cell lung cancer (NSCLC) harbouring EGFR activating mutations. Here we aim to discern efficacy and toxicity measures through a meta-...

Descripción completa

Detalles Bibliográficos
Autores principales: De Mello, Ramon Andrade, Escriu, Carles, Castelo-Branco, Pedro, Cabral, Paloma Lucena, Mountzios, Giannis, Lopes, Gilberto de Lima, Madureira, Pedro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5837761/
https://www.ncbi.nlm.nih.gov/pubmed/29545937
http://dx.doi.org/10.18632/oncotarget.23668

Ejemplares similares

Ejemplares similares